Results

Total Results: 8,502 records

Showing results for "treated".

5541. In Conversation With... Cindy Brach | PSNet
      psnet.ahrq.gov/perspective/conversation-cindy-brach
      December 27, 2019 - rights argument that says patients have the right to be able to communicate in healthcare and to be treated

5542. women-hiv-protocol-160301 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
      March 01, 2016 - HIV-positive antiretroviral-treated aging women who achieve viral suppression are in a generalized status

5543. Har 2005 (pdf file)
      hcup-us.ahrq.gov/reports/annualreport/HAR_2005.pdf
      January 01, 2005 - report includes information from the most recent database containing discharge records for all patients treated … O s p ita L-B a s e d c a r e in tH e u n ite d s tate s , 2 0 0 5 ■ Conditions treated … Data on conditions treated in the hospi- tal, as well as information on medical and surgical procedures … The most costly diagnoses: ■ The two most costly conditions treated in U.S. hospitals in 2005 were … Influenza sectiOn 3—prOcedures Because the NIS is limited to inpatient hospital data, conditions treated

5544. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
      September 15, 2013 - Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results

5545. Disposition of Comments Report for Comparative Effectiveness Review #68 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
      July 01, 2012 - Disposition of Comments Report for Comparative Effectiveness Review #68 http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1180 Published Online: July 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research Re…

5546. Payer Readiness for Technology Implementation (P-RTI) Tool Application and Assessment - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs024086-molfenter-final-report-2018.pdf
      January 01, 2018 - Payer Readiness for Technology Implementation (P-RTI) Tool Application and Assessment - Final Report Title: Payer Readiness for Technology Implementation (P-RTI) Tool Application and Assessment Principal …

5547. Final Progress Report: Opioid Stewardship in Urology (pdf file)
      www.ahrq.gov/sites/default/files/2024-01/smith-report.pdf
      January 01, 2024 - Final Progress Report: Opioid Stewardship in Urology Opioid Stewardship in Urology American Urological Association (AUA) Quality Improvement Summit December 8, 2018 Team Members. Presenters Gregory Auffenberg, MD, Northwestern University Angela B. Smith, MD, MS, University of North Carolina Timothy D. Averch, …

5548. Title Page (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015124-selker-final-report-2008.pdf
      January 01, 2008 - Title Page Grant Final Report Grant ID: 5UC1HS015124-03 EMS Based TIPI-IS Cardiac Care QI/Error Reduction System Inclusive dates: 09/30/04 - 03/31/08 Principal Investigator: Harry P. Selker, MD, MSPH Team members: Denise Daudelin, RN, MPH * Manlik Kwong, BS * William Lane, BS * Rob…

5549. REQUEST FOR TASK ORDER (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
      April 01, 2010 - REQUEST FOR TASK ORDER The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ's Effective Health Care Program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The DEcIDE network…

5550. CER 220: Disposition of Comments Report for Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-disposition-comments-analgesics-prehospital-setting.pdf
      September 03, 2019 - The result could be substantially under treated pain. … of pain may be neglected in prehospital environment there are clear directives that it should be treated

5551. Final Evidence Summary: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/cognitive-impairment-in-older-adults-screening
      February 25, 2020 - Effects of cognitive-communication stimulation for Alzheimer’s disease patients treated with donepezil

5552. Vte-Prophyalaxis Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
      May 01, 2013 - rates of major bleeding comparing prophylactic rivaroxaban with enoxaparin in patients concomitantly treated … rates of major bleeding comparing prophylactic dabigatran with enoxaparin in patients concomitantly treated … in rates of major bleeding with prophylactic rivaroxaban or enoxaparin in patients concomitantly treated … differences in rates of major bleeding with prophylactic dabigatran or enoxaparin in patients concomitantly treated

5553. Heart-Failure-Natriuretic-Peptide Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
      November 01, 2013 - Once a diagnosis of HF has been made, patients are treated. … KQ6: Adults being treated for chronic HF. KQ7: Adults with and without HF. … treatment for HF was guided by BNP or NT-proBNP displayed improved outcomes compared with patients treated … Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated

5554. Dietary-Supplements Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
      January 01, 2013 - Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and … Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin- treated patients … controlled double blinded trial of Vascepa (AMR101) + statins (ANCHOR) 702 high-risk statin-treated … LDL particle concentration declined numerically more in statin-treated patients than among those not

5555. Evidence-based Practice Center Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
      December 01, 2010 - database: • Completed: the study has concluded normally; participants are no longer being examined or treated … participants has halted prematurely and will not resume; participants are no longer being examined or treated … Conference and meeting abstracts were treated separately from publications, as many studies presented … The completeness rates (participants are no longer being examined or treated) were analyzed for registered

5556. Facts and Figures 2006
      hcup-us.ahrq.gov/reports/factsandfigures/facts_figures_2006.jsp
      January 01, 2006 - This report includes information from the 2006 database containing discharge records for all patients treated … Data on conditions treated in the hospital, as well as information on medical and surgical procedures … The most costly diagnoses: The three most costly conditions treated in U.S. hospitals in 2006 were … Conditions treated with expensive technology or requiring intensive care—including spinal cord injuries

5557. Archived: Evidence Summary: Osteoporosis: Screening 2011 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary6/osteoporosis-screening-2011
      July 06, 2010 - recommendations for screening and treatment from several groups, osteoporosis is underdetected and inadequately treated … The FDA issued an interim report of an ongoing review based on data from nearly 20,000 patients treated … Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene … A report from the FDA based on data from nearly 20,000 patients treated with bisphosphonates in placebo-controlled

5558. MAINTAIN AND EXPAND (pdf file)
      hcup-us.ahrq.gov/reports/methods/1998ChangesintheNISRedesignFinal.pdf
      January 18, 2002 - In the course of analyzing stratification variables, we found that patients treated in rehabilitation … Our analysis clearly illustrates that patients treated in rehabilitation hospitals tend to have lower … ) 42 Changes in NIS Design To better investigate the accuracy of the estimates, we temporarily treated … that HCUP hospitals are similar to non-HCUP hospitals within a stratum, the sample hospitals can be treated

5559. Vision Screening in Children Aged 6Months to 5 Years: Evidence Report and Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jwn6dWRHvK3C9oJCV6hLKc
      September 05, 2017 - after 5 to 12 weeks for children pretreated with glasses (2 RCTs, 240 participants); more children treated … eyeglass prescriptions until visual acuity in the amblyopic eye stopped improving44; another trial treated … improved visual acuity by a mean of 0.7 of a line on a standard visual acuity chart, and more children treated … participants achieved a clinically mean­ ingful change, although 1 trial reported that more children treated

5560. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
      July 01, 2014 - Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with … Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. … Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. … The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic